EUCTR2015-000377-12-FR
进行中（未招募）
1 期
MISOBOLD - Prostate cancer hypoxia using BOLD MRI and 18F-FMISO PET imaging - MISOBOLD
CHU de Bordeaux0 个研究点目标入组 20 人2017年7月12日
概览
- 阶段
- 1 期
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- CHU de Bordeaux
- 入组人数
- 20
- 状态
- 进行中（未招募）
- 最后更新
- 8年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Patient above 18 yrs old.
- •Prostate tumor with histological confirmed diagnosis and highly radiological suspected target on MRI
- •High risk patient : \>T2c grade, Glasgow score \> 7 and PSA \> 20ng/ml
- •Surgical treatment chosen during multidisciplinary meeting
- •Patient must have undergone MRI with BOLD sequence less than 6 month prior surgery
- •Informed signed consent.
- •Member or beneficiary of a social security system.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
排除标准
- •Patient included in another clinical study
- •Geographical, social or psychological reasons preventing patient from submitting to the study’s medical monitoring
- •Patient deprive of liberty, adult subjects to legal protection or unable to give consent
- •Contraindication to MRI
- •Contraindication to gadolinium injection
结局指标
主要结局
未指定
相似试验
撤回
不适用
MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET ImagingProstate CancerNCT03293602University Hospital, Bordeaux
已完成
不适用
The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate CancerProstate CancerNCT00242073University Health Network, Toronto
撤回
不适用
MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation TherapyProstate CancerNCT00963300University of Texas Southwestern Medical Center
撤回
不适用
Characterize Tumor Hypoxia by Magnetic Resonance ImagingProstate CancerProstate TumorNCT03987568Wake Forest University Health Sciences
已完成
不适用
Detecting local recurrent prostate cancer: MRI:patterns of post-prostatectomy recurrence and of its response to salvege radiotherapy using Enhanced and Dynamic Contrast Enhanced (DCE) MRIC61Malignant neoplasm of prostateDRKS00003469niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde33